Datasets
The dataset has been developed for the reporting of primary cancer resection and biopsy specimens of malignancies arising from the major salivary glands (parotid, submandibular and sublingual glands). For resections of recurrent disease, the reporting guide may be used pragmatically although some data elements may be not applicable nor assessable. Melanomas, lymphomas, and sarcomas are dealt with in separate ICCR datasets. Minor salivary gland malignancies arising in the oral cavity, nasal cavity and paranasal sinuses, larynx, hypopharynx, trachea, nasopharynx, oropharynx, gnathic bones, and ear-temporal bone specimens are staged according to their anatomical sub-site and are dealt with in separate ICCR datasets. Minor salivary gland tumours are rare with insufficient quality evidence currently to support a separate dataset, recognising this is a limitation. Further, the ICCR follows Union for International Cancer Control (UICC) guidance for staging, and the major salivary gland system is not applicable to minor salivary glands. The notes on histological typing and grading in this dataset may be used to inform reporting of minor salivary gland malignancies. In addition, neck dissections and nodal excisions are dealt with in a separate dataset, and this dataset should be used in conjunction, where applicable.
For bilateral tumours, a separate dataset should be completed for each tumour.
These datasets were developed with the kind support of the North American Society of Head and Neck Pathology (NASHNP), American Academy of Oral and Maxillofacial Pathology (AAOMP), International Association of Oral and Maxillofacial Pathologists (IAOP), and British Society for Oral and Maxillofacial Pathology (BSOMP).
2nd edition – July 2024
Updated following the publication of the 2024 World Health Organization (WHO) Classification of Head and Neck Tumours, 5th edition.
SUMMARY OF CHANGES
• Added a new element ‘Clinical information’.
• Updated the ‘Specimen(s) submitted’ element.
• Updated the ‘Tumour site’ element.
• Added a separate element ‘Tumour laterality’.
• Added a new element ‘Block identification key’.
• Updated the ‘Histological tumour type’ element.
• Updated the ‘Histological tumour grade’ element.
• Updated the ‘Extent of invasion’ element.
• Updated the ‘Coexistent pathology’ element.
• Updated the ‘Ancillary studies’ element.
• Other minor updates to elements were also included.
• Revised all notes, including incorporation of the most recent 2024 WHO Classification.
1st edition – September 2018
Authors of the previous edition of this dataset are available here.
